Get the Stockscreener App
6.61
1.05%
-0.07
After Hours:
6.59
-0.02
-0.30%
Ardelyx Inc stock is traded at $6.61, with a volume of 2.33M.
It is down -1.05% in the last 24 hours and up +18.04% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$6.68
Open:
$6.68
24h Volume:
2.33M
Relative Volume:
0.57
Market Cap:
$1.59B
Revenue:
$386.15M
Net Income/Loss:
$-56.39M
P/E Ratio:
-28.74
EPS:
-0.23
Net Cash Flow:
$-55.19M
1W Performance:
+1.38%
1M Performance:
+18.04%
6M Performance:
+21.51%
1Y Performance:
+6.27%
1-Day Range:
$6.58
$6.69
1-Week Range:
$6.37
$6.78
52-Week Range:
$3.21
$7.18
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.61 | 1.60B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
Cubist Systematic Strategies LLC Grows Stock Position in Ardelyx, Inc. $ARDX - MarketBeat
Adage Capital Partners GP L.L.C. Grows Holdings in Ardelyx, Inc. $ARDX - MarketBeat
Two Seas Capital LP Purchases 265,000 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Dynamic Technology Lab Private Ltd Makes New Investment in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx, Inc. $ARDX Shares Sold by Hsbc Holdings PLC - MarketBeat
Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN
Ardelyx at H.C. Wainwright Conference: Strategic Growth and Challenges - Investing.com
Is Ardelyx Inc. affected by consumer sentimentTrade Exit Report & Fast Moving Market Watchlists - Lancaster City Council
Invesco Ltd. Acquires 52,584 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx at Morgan Stanley Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Will Ardelyx Inc. outperform small cap indexesJuly 2025 Closing Moves & Consistent Profit Focused Trading Strategies - beatles.ru
Ardelyx at Morgan Stanley Conference: Strategic Growth Amid Challenges - Investing.com
Ardelyx (NASDAQ:ARDX) Coverage Initiated by Analysts at Raymond James Financial - MarketBeat
Ardelyx, Inc. $ARDX Shares Purchased by Russell Investments Group Ltd. - MarketBeat
Panagora Asset Management Inc. Has $3.35 Million Stock Holdings in Ardelyx, Inc. $ARDX - MarketBeat
Ieq Capital LLC Purchases New Stake in Ardelyx, Inc. $ARDX - MarketBeat
Using fundamentals and technicals on Ardelyx Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
ADAR1 Capital Management LLC Raises Stock Holdings in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx (ARDX) Receives a Buy from Citi - The Globe and Mail
Analysts Expect Breakeven For Ardelyx, Inc. (NASDAQ:ARDX) Before Long - 富途牛牛
Is Ardelyx Inc. exposed to currency risks2025 Investor Takeaways & Comprehensive Market Scan Reports - خودرو بانک
Has Ardelyx Inc. found a price floorJuly 2025 Volume & Fast Moving Market Watchlists - Newser
Published on: 2025-09-05 14:13:35 - Newser
Strategies to average down on Ardelyx Inc.Dividend Hike & Weekly Consistent Profit Watchlists - Newser
Will Ardelyx Inc. price bounce be sustainableMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - Newser
What technical models suggest about Ardelyx Inc.’s comebackCEO Change & Accurate Intraday Trade Tips - Newser
Walleye Capital LLC Acquires Shares of 144,304 Ardelyx, Inc. $ARDX - MarketBeat
Published on: 2025-09-05 01:26:22 - Newser
Live market analysis of Ardelyx Inc.July 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Is Ardelyx Inc. a play on infrastructure spendingLong Setup & Long-Term Safe Investment Plans - خودرو بانک
Ardelyx at Cantor Global Healthcare: Strategic Growth and Market Challenges - Investing.com
Is Ardelyx Inc. showing signs of accumulationJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
How to forecast Ardelyx Inc. trends using time seriesJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Ardelyx Inc. stock outlook for YEARPortfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Ardelyx’s Strategic Momentum in Global Markets: Evaluating Near-Term Catalysts - AInvest
Ardelyx at Citi’s Biopharma Conference: Strategic Growth Plans - Investing.com
Regression analysis insights on Ardelyx Inc. performanceQuarterly Earnings Summary & Low Risk Entry Point Guides - Newser
Will breakout in Ardelyx Inc. lead to full recoveryBreakout Watch & Step-by-Step Swing Trade Plans - Newser
Leading vs lagging indicators on Ardelyx Inc. performanceWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
How Ardelyx Inc. stock performs during market volatilityTrend Reversal & Weekly Setup with High ROI Potential - Newser
How to interpret RSI for Ardelyx Inc. stockWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):